Withdrawal: "A novel AKR1C3 specific prodrug TH3424 with potent anti-tumor activity in liver cancer" Ping He, Chunnian Wang, Yanlan Wang, Caiyan Wang, Changhua Zhou, Donglin Cao, Jiang Li, David A. Bushnell, Qing Li, Roger D. Kornberg, Wei Xie, Zhong Wang.
The above article from Clinical Pharmacology & Therapeutics published online on October 25, 2019 in Wiley Online Library (http://wileyonlinelibrary.com) has been withdrawn by agreement among the Journal Editor-in-Chief Scott A. Waldman, and Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology & Therapeutics. The withdrawal has been agreed due to ongoing internal investigations into the origin of the data used within the article.